HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine, and normal saline.

Abstract
This double-blind, randomized study was designed to compare the effectiveness of intravenous regional sympatholysis using guanethidine, reserpine and normal saline. Twenty-one patients with reflex sympathetic dystrophy of an upper or lower extremity were enrolled and received intravenous regional blockade (IVRB) with one of the three medications. There was significant pain relief in all three groups at 30 min. There were no significant differences among the three groups in the degree of pain relief, the number of patients obtaining pain relief in the 30 min after the block, or the number of patients reporting more than 50% pain relief for more than 24 hr. The saline group's high rate of pain relief could be partially due to a mechanism of tourniquet-induced analgesia.
AuthorsJ Blanchard, S Ramamurthy, N Walsh, J Hoffman, L Schoenfeld
JournalJournal of pain and symptom management (J Pain Symptom Manage) Vol. 5 Issue 6 Pg. 357-61 (Dec 1990) ISSN: 0885-3924 [Print] United States
PMID2269803 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Sodium Chloride
  • Reserpine
  • Guanethidine
Topics
  • Adult
  • Aged
  • Autonomic Nerve Block (methods)
  • Double-Blind Method
  • Guanethidine (administration & dosage)
  • Humans
  • Middle Aged
  • Reflex Sympathetic Dystrophy (therapy)
  • Reserpine (administration & dosage)
  • Sodium Chloride (administration & dosage)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: